KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Current Assets (2016 - 2026)

Pfizer has reported Current Assets over the past 18 years, most recently at $42.8 billion for Q1 2026.

  • Quarterly Current Assets fell 6.63% to $42.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $42.8 billion through Mar 2026, down 6.63% year-over-year, with the annual reading at $42.9 billion for FY2025, 14.81% down from the prior year.
  • Current Assets was $42.8 billion for Q1 2026 at Pfizer, roughly flat from $42.9 billion in the prior quarter.
  • Over five years, Current Assets peaked at $74.0 billion in Q4 2023 and troughed at $5.9 billion in Q4 2022.
  • The 5-year median for Current Assets is $45.9 billion (2025), against an average of $48.0 billion.
  • Year-over-year, Current Assets skyrocketed 1147.67% in 2023 and then tumbled 48.43% in 2024.
  • A 5-year view of Current Assets shows it stood at $51.3 billion in 2022, then fell by 15.46% to $43.3 billion in 2023, then grew by 16.21% to $50.4 billion in 2024, then decreased by 14.81% to $42.9 billion in 2025, then decreased by 0.18% to $42.8 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Current Assets are $42.8 billion (Q1 2026), $42.9 billion (Q4 2025), and $46.9 billion (Q3 2025).